Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Vaishali Pharma Limited (NSE: VAISHALI), ISIN INE972X01022 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
VAISHALI last traded at ₹8.35 (-1.18%), with a 52-week range of ₹4.75 to ₹12.20 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 31.61%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 64/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.